CAS 151767-02-1 | Montelukast Sodium
CAS:151767-02-1
MF:C35H37ClNNaO3S
MW:610.18
EINECS:604-813-7
MDL No.:MFCD00931431
Properties
Appearance white to tan powder
Melting point:115 °C(dec.)
storage temp. 2-8°C
solubility DMSO: ≥8mg/mL at 60°C
optical activity[α]/D +90 to +106° in methanol (c=1)
Application:
Montelukast sodium, [R - (E)] -1-ff [1- [3- [2- [7-chloro-2-quinoline) vinyl] phenyl-3- [2- (1-hydroxy-1-methylethyl) phenyl] propyl] thio] methyl] cyclopropane sodium acetate, molecular formula: C35H35CINNaO3S. Montelukast can effectively slow down or even prevent dementia in the elderly. Montelukast can increase the growth rate of nerve cells in young mice by 50%.
| Application Area | Description |
|---|---|
| Asthma | Maintenance Treatment: Used for the prevention and chronic treatment of asthma in adults and pediatric patients (as young as 12 months old).Exercise-Induced Bronchoconstriction: Used to prevent bronchoconstriction induced by exercise. |
| Allergic Rhinitis | Hay Fever: Relieves symptoms such as nasal congestion, runny nose, and sneezing caused by seasonal or perennial allergies. |
| Pediatrics | Available in chewable tablets and oral granules, making it suitable for young children who cannot swallow regular tablets. |
Related Intermediate Chemicals
The synthesis of Montelukast involves the coupling of three main fragments: a quinoline moiety, an ethanol side chain, and a mercaptobenzothiophene group.
Here are the critical intermediates involved in the synthesis:
| Intermediate Name | CAS Number | Role in Synthesis |
|---|---|---|
| (R)-1-[(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propanol | 151767-03-2 | The Free Alcohol (Montelukast Alcohol). This is the immediate precursor to the final drug. It is converted to the mesylate (or tosylate) and then reacted with thiol. |
| 6-Acetyl-2-mercaptobenzo[b]thiophene | 1128-00-9 | The Thiol Source. This is the source of the benzothiophene ring and the sulfur atom that forms the thioether linkage in the final product. |
| (E)-1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-1-propanone | 136760-02-8 | The Quinoline Ketone. A mian intermediate in the construction of the left-hand side (quinoline) fragment. |
| 7-Chloro-2-trifluoromethanesulfonyloxyquinoline | 151550-08-2 | A triflate intermediate used in the synthesis of the quinoline ring system via palladium-catalyzed coupling reactions. |
| 2-(2-Bromoethyl)acetophenone | 18366-82-4 | A building block used in the synthesis of the central propanol chain and the isopropyl phenyl group. |
Summary of the Synthetic Route
A typical synthetic route involves:
Fragment A (Quinoline): Synthesis of the 7-chloroquinoline derivative with a vinyl group attached to a phenyl ring.
Fragment B (Chain): Synthesis of the chiral propanol chain containing the isopropyl phenyl group.
Coupling (A+B): Fragment A and Fragment B are coupled, often via a Grignard reaction, to form the Montelukast Alcohol (the tertiary alcohol intermediate).
Activation: The alcohol group is activated (e.g., converted to a mesylate).
Thiol Coupling: The activated alcohol is reacted with 6-Acetyl-2-mercaptobenzo[b]thiophene to form the thioether bond.
Salt Formation: The resulting free acid (after hydrolysis of the acetyl group) is neutralized with sodium hydroxide to form Montelukast Sodium.
Synonyms:
151767-02-1
Singulair
Montelukast sodium salt
MK-476
Montelukast monosodium salt
sodium (R,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetate
Montelukast sodium hydrate
151767-02-1 (sodium)
Cyclopropaneacetic acid, 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, sodium salt, (R-(E))-
Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
Hot Tags: CAS 151767-02-1 | Montelukast Sodium, China CAS 151767-02-1 | Montelukast Sodium manufacturers, suppliers, Excipient, 2 Trifluoromethyl 5 thiazolecarboxylic acid ethyl ester, 3 Acetamidophthalic anhydride, 2-Aminopyrimidine, Pcbth-co-thmaa, TRANS TRANS FARNESYL BROMIDE


